Epidermal innervation in type 1 diabetic patients: a 2.5-year prospective study after simultaneous pancreas/kidney transplantation
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
18443196
PubMed Central
PMC2494625
DOI
10.2337/dc07-2409
PII: dc07-2409
Knihovny.cz E-resources
- MeSH
- Diabetes Mellitus, Type 1 blood pathology physiopathology surgery MeSH
- Diabetic Nephropathies blood pathology surgery MeSH
- Diabetic Neuropathies pathology MeSH
- Adult MeSH
- Biopsy, Needle MeSH
- Blood Glucose metabolism MeSH
- Skin innervation pathology MeSH
- Humans MeSH
- Follow-Up Studies MeSH
- Nerve Fibers physiology MeSH
- Perception MeSH
- Prospective Studies MeSH
- Reference Values MeSH
- Kidney Transplantation * MeSH
- Pancreas Transplantation * MeSH
- Vibration MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Blood Glucose MeSH
OBJECTIVE: To assess the effect of normoglycemia following simultaneous pancreas/kidney transplantation (SPK) on neurological function and intraepidermal nerve fiber density (IENFD) in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: We performed vibration perception threshold (VPT) testing and autonomic function testing (AFT) and assessed IENFD in skin biopsies from the lower thigh and upper calf in 14 healthy control subjects and 18 patients with type 1 diabetes at the time of and at 21-40 (median 29) months post SPK. RESULTS: At baseline, significantly increased VPTs, pathological AFT results, and severe reduction in IENFD were present in SPK recipients. After SPK, an increase of IENFD in the thigh of more than one epidermal nerve fiber per millimeter was noted in three patients (median 4.1, range 1.9-10.2), but changes were not significant for the group as a whole. CONCLUSIONS: We conclude that either irreversible nerve damage might be present in some SPK recipients or that longer periods of normoglycemia might be needed to allow nerve regeneration.
See more in PubMed
Boulton AJM, Malik RA, Arezzo JC, et al.: Diabetic somatic neuropathies. Diabetes Care 27:1458–1486, 2004 PubMed
Navarro X, Sutherland DER, Kennedy WR: Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 42:727–736, 1997 PubMed
Kennedy WR, Wendelschafer-Crabb G, Johnson T: Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47:1042–1048, 1996 PubMed
Boucek P, Havrdova T, Voska L, et al.: Severe depletion of intraepidermal nerve fibres in skin biopsies of pancreas transplant recipients. Transplant Proc 37:3574–3575, 2005 PubMed
Kennedy WR, Wendelschafer-Crabb G, Polydefkis M, et al.: Pathology and quantitation of cutaneous nerves. In Peripheral Neuropathy, 4th ed. Dyck PJ, Thomas PK, Eds. Philadelphia, Saunders, 2005, p. 869–896
Howorka K, Pumprla J, Schabmann A: Optimal parameters of short-term heart rate spectrogram for routine evaluation of diabetic cardiovascular autonomic neuropathy. J Auton Nerv Syst 69:164–172, 1998 PubMed
Del Carro U, Fiorina P, Amadio S, et al.: Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation. Diabetes Care 30:3063–3069, 2007 PubMed
Quattrini C, Tavakoli M, Jeziorska M, et al.: Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56:2148–2154, 2007 PubMed
Mehra S, Tavakoli M, Kallinikos PA, et al.: Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 30:2608–2612, 2007 PubMed
Fioretto P, Steffes MW, Sutherland DE, et al.: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69–75, 1998 PubMed
Matricali GA, Bammens B, Kuypers D: High rate of Charcot foot attacks early after simultaneous pancreas-kidney transplantation. Transplantation 83:245–246, 2007 PubMed